| Application no. and date | 17740200.5 (espacenet) (Federated) (European Patent Register), 20170630 | | Patent/reg. no. and date | DK/EP 3478713, 20220511 | | Publication date | 20190508 | | Priority no. and date | US 201662357151 P, 20160630 | | EP pub. no. and date |
EP 3478713 20190508 | | Effective date | | | Applicant/owner | Prothena Biosciences Limited, 77 Sir John Rogerson's Quay, Block C
Grand Canal Docklands
Dublin 2, D02 VK60, IE | | Applicant ref. no. | V443996DK00 | | Inventor | KINNEY, Gene G., 1600 Forest View Avenue
Burlingame, California 94010, US,
GUTHRIE, Spencer D., 208 2nd Avenue
San Francisco, California 94118, US,
KOLLER, Martin, P.O.BOX 2690
Rancho Santa Fe, California 92067, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 25/02 (2006.01) , C07K 16/18 (2006.01) | | Title | Sammensætninger til behandling af amyloidose | | Int. application no. | US2017040289 | | Int. publication no. | WO2018005967 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
